ViiV Healthcare (GSK) Director, Access Strategy, Portfolio and Pipeline Innovation

Job description

ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV.  We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care.  We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic. We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference. While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities. This role is based at ViiV Healthcare’s U.S. headquarters in Durham, NC and follows a hybrid working model, requiring a minimum of 2 days per week onsite. Candidates who do not currently live within commuting distance of Durham will be required to relocate to North Carolina. This role is eligible for a domestic relocation package. Check out this link to learn more about the thriving, diverse, and cutting edge RTP area! Research Triangle Park | Where People + Ideas Converge (rtp.org) The Director, Access Strategy, Portfolio and Pipeline Innovation will serve as the US Market Access strategic lead for selected in-line portfolio initiatives, including loss-of-exclusivity and other lifecycle transitions, and for selected pre-launch pipeline assets. The role will translate anticipated changes in the US access, reimbursement, pricing, and policy environment into clear implications and recommendations for product development, evidence generation, investment, and commercialization decisions. Working closely with cross-functional partners, the Director will ensure that US payer, purchaser, channel, and patient-access requirements are incorporated early and consistently across the product lifecycle. This position requires enterprise-level influence, strong strategic judgment, and the ability to lead through ambiguity. The Director will connect external market signals with portfolio choices, identify potential access risks and opportunities, and drive cross-functional alignment on strategies that support sustainable patient access and long-term portfolio value. The Director will own Access Strategy & Marketing recommendations for assigned lifecycle and pipeline initiatives. Brand-aligned Access Strategy Directors will retain ownership of in-line brand access strategy and execution, while Portfolio Access & Optimization will remain a critical partner in portfolio analytics, optimization, and cross-portfolio planning. Responsibilities will be aligned through initiative-specific charters and joint work plans. Reporting to the Senior Director, Access Strategy & Marketing, the Director, Access Strategy – Lifecycle & Pipeline will lead the development of integrated US market access strategies for priority lifecycle, portfolio, policy, and pipeline initiatives across ViiV Healthcare’s HIV treatment and prevention portfolio. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: Portfolio and lifecycle access strategy Lead US market access strategy for assigned portfolio and lifecycle priorities, including loss-of-exclusivity, indication expansion, formulation or dosing evolution, and other events that could materially affect access, reimbursement, or portfolio value. Lead the development of the US access strategy for products facing loss-of-exclusivity, integrating payer behavior, channel dynamics, competitor evolution, and implications for the broader ViiV portfolio. Ensure lifecycle strategies consider the interdependencies among oral treatment, long-acting treatment, prevention, emerging competitors, and future ViiV assets. Partner with brand-aligned Access Strategy Directors to ensure that portfolio-level recommendations translate into coordinated product strategies and execution. Pipeline and commercialization strategy Serve as the US Market Access lead for assigned early- and late-stage pipeline assets, embedding payer, purchaser, provider, channel, and patient-access insights into development and commercialization strategies. Define the access ambition, critical success factors, and minimum and aspirational access requirements for pipeline assets in partnership with Global Market Access and US cross-functional stakeholders. Shape target product profiles, value propositions, evidence plans, pricing hypotheses, channel strategies, and launch assumptions from a US access perspective. Translate emerging long-acting treatment and next-generation PrEP concepts into actionable access hypotheses, including benefit design, site-of-care, acquisition, reimbursement, distribution, and patient-start considerations. Policy and external-environment strategy Establish a structured process to monitor, assess, and communicate external developments that could affect ViiV’s portfolio, including government pricing policy, Medicaid eligibility and financing changes, PBM and payer-model evolution, reimbursement reform, and channel consolidation. Translate external policy developments into product-level and portfolio-level implications, including potential effects on access, evidence needs, channel economics, and patient affordability. Develop scenario analyses and strategic recommendations for high-impact policy risks in partnership with cross-functional subject-matter experts in Government Relations. Provide senior leaders with concise, decision-oriented assessments of major external access developments rather than descriptive policy updates alone. Why You? Basic Qualifications We are seeking professionals with the following required skills and qualifications to help us achieve our goals: Bachelor’s degree and 5+ years of pharmaceutical, biotechnology, payer, and consulting experience OR healthcare experience Experience developing market access strategy for lifecycle, pipeline, launch, policy, pricing, reimbursement, or portfolio initiatives. Experience with both commercial and government payer segments, including PBMs, health plans, employers, Medicaid, and Medicare. Experience translating policy, payer, pricing, and reimbursement developments into product and portfolio implications. Experience leading cross-functional initiatives. Experience developing executive-level recommendations. Preferred Qualification If you have the following characteristics, it would be a plus: Advanced degree in business, public health, health economics, pharmacy, public policy, or a related discipline. 3+ years of experience in Market Access. Experience in or understanding of the HIV therapeutic area Experience supporting pipeline assets through development, evidence planning, governance, or launch-readiness milestones. Experience with lifecycle strategy or l